NDC 72603-313-01 - Lansoprazole
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72603-313
- Requested NDC
- 72603-313-01
- Package NDCs from labels
- 72603-313-01, 72603-313-10
- Manufacturer
- NorthStar Rx LLC | Aurobindo Pharma Limited
- Effective date
- 2024-08-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lansoprazole - NorthStar Rx LLC | Aurobindo Pharma Limited | NorthStar Rx LLC | Aurobindo Pharma Limited | 2024-08-08 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72603-313-01 | Lansoprazole | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING, D | 10 | 1 | |
| 72603-313-10 | Lansoprazole | 10 in 1 CARTON | TABLET, ORALLY DISINTEGRATING, D | 10 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72603-313-01 | EA - Each | 72603-313 | 01a4d3f8-7c8a-4a06-9b63-2c54fb50f962 | 1 | 2025-02-10 |
| 72603-313-10 | EA - Each | 72603-313 | 566ce292-033b-4f15-89b4-c7779b7f898c | 1 | 2025-02-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION | Fenwal, Inc. | d55cb701-9664-4931-8754-1a8cae68da06 | 2022-11-01 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) SOLUTION | Fenwal, Inc. | f9d7f1b4-7a77-44f9-8924-10b16008b49d | 2022-11-01 | XF417D3PSL | |
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) | Fenwal, Inc. | 4a08a9ec-46a5-4fcf-80ee-5c33f1a8b746 | 2022-11-01 | XF417D3PSL | |
| Lansoprazole | LANSOPRAZOLE | Proficient Rx LP | 3e3e63df-e2ad-420b-acb9-28e65ea6fb07 | 2022-10-01 | Warnings, Adverse reactions | 0K5C5T2QPG |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | ebd0839e-2e1d-4e0e-986c-19f1f5c76358 | 2022-09-19 | Warnings | 6OZP39ZG8H |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 | Allergan, Inc. | aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0 | 2022-09-01 | Warnings | 6OZP39ZG8H |
| Hendel Periodontal and Tooth Pain Relief | SODIUM BORATE, TRIBASIC CALCIUM PHOSPHATE, MERCURIUS SOLUBILIS, AND SILICON DIOXIDE | MediNatura Inc | f34e9f77-69fd-4c7f-9eea-2d721a4d27fb | 2022-08-22 | Warnings | ETJ7Z6XBU4 |
| LANSOPRAZOLE | LANSOPRAZOLE | Zydus Pharmaceuticals USA Inc. | 9b3869ad-f2f7-4954-b75c-5c23b8951635 | 2022-08-22 | Warnings, Adverse reactions | 351260 351261 0K5C5T2QPG |
| Magnesia Carbonica | MAGNESIA CARBONICA | Hahnemann Laboratories, INC. | e4310548-b362-a2c6-e053-2a95a90ac607 | 2022-07-19 | 0E53J927NA | |
| REFRESH Optive Mega-3 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | c5f2b3f2-2071-45bd-a010-67f848bc0233 | 2022-06-30 | Warnings | 6OZP39ZG8H |
| Lansoprazole | LANSOPRAZOLE | BluePoint Laboratories | 924c5a35-4804-4e14-a2fc-2b84d186d257 | 2022-06-20 | Warnings, Adverse reactions | 0K5C5T2QPG |
| Lansoprazole | LANSOPRAZOLE | Teva Pharmaceuticals USA, Inc. | 6b8dd0e1-cd69-4f9a-887f-e42627b5d78e | 2022-04-29 | Warnings, Adverse reactions | 351260 351261 0K5C5T2QPG |
| ACD Blood-Pack Units (PL 146 PLASTIC) | ANTICOAGULANT CITRATE DEXTROSE (ACD) | Fenwal, Inc. | ba894daa-688e-4a9e-bd74-e71797f951bb | 2022-04-27 | XF417D3PSL | |
| Lansoprazole | LANSOPRAZOLE | Xiromed LLC | 00a574e0-bd03-deea-9f85-b108f78982ba | 2022-04-15 | Warnings, Adverse reactions | 0K5C5T2QPG |
| ALPHA SH | SANGUINARIA CANADENSIS ROOT, GOLDENSEAL, SILICON DIOXIDE, POTASSIUM CHLORIDE, PULSATILLA VULGARIS | Schwabe Mexico, S.A. de C.V. | 3e2e5f52-db54-4635-83a8-a67a683c093c | 2022-03-22 | Warnings | ETJ7Z6XBU4 |
| ALPHA SH | SANGUINARIA CANADENSIS ROOT, GOLDENSEAL, SILICON DIOXIDE, POTASSIUM CHLORIDE, PULSATILLA VULGARIS | Schwabe North America, Inc. | 94de9ce3-6ee9-4322-bda2-0b4391f09d87 | 2022-03-22 | Warnings | ETJ7Z6XBU4 |
| Lansoprazole | LANSOPRAZOLE | Dr.Reddy's Laboratories Ltd. | 82174fcc-1b0f-2068-7fc4-db335b43b5e2 | 2022-03-21 | Warnings, Adverse reactions | 0K5C5T2QPG |
| Ear Care | ECHINACEA, HYDRASTIS CANADENSIS, APIS MELLIFICA, ARSENICUM ALBUM, BELLADONNA, BRYONIA, CAPSICUM ANNUUM, CAUSTICUM, CINCHONA OFFICINALIS, CONIUM MACULATUM, DULCAMARA, FERRUM PHOSPHORICUM, HEPAR SULPHURIS CALCAREUM, KALI SULPHURICUM, LYCOPODIUM CLAVATUM, MERCURIUS VIVUS, MEZEREUM, PHOSPHORUS, PLANTAGO MAJOR, PULSATILLA, SILICEA, VERBASCUM THAPSUS, TELLURIUM METALLICUM, INFLUENZINUM | Newton Laboratories, Inc. | da807eb3-34a3-61b9-e053-2995a90a0e21 | 2022-03-18 | Warnings | ETJ7Z6XBU4 |
| Ear Care | INFLUENZINUM, TELLURIUM METALLICUM, APIS MEL., ARSENICUM ALB., BELLADONNA, BRYONIA, CAPSICUM, CAUSTICUM, CINCHONA, CONIUM, DULCAMARA, FERRUM PHOSPHORICUM, HEPAR SULPH. CALC.,KALI SULPH., LYCOPODIUM, MERC. VIV., MEZEREUM, PHOSPHORUS, PLANTAGO, PULSATILLA, SILICEA, VERBASCUM, ECHINACEA, HYDRASTIS | Newton Laboratories, Inc. | da80a5ea-f603-719e-e053-2995a90a9710 | 2022-03-18 | Warnings | ETJ7Z6XBU4 |
| Ear Care | INFLUENZINUM, TELLURIUM METALLICUM, APIS MEL., ARSENICUM ALB., BELLADONNA, BRYONIA, CAPSICUM, CAUSTICUM, CINCHONA, CONIUM, DULCAMARA, FERRUM PHOSPHORICUM, HEPAR SULPH. CALC.,KALI SULPH., LYCOPODIUM, MERC. VIV., MEZEREUM, PHOSPHORUS, PLANTAGO, PULSATILLA, SILICEA, VERBASCUM, ECHINACEA, HYDRASTIS | Newton Laboratories, Inc. | da81b21a-090a-dabf-e053-2995a90aa05e | 2022-03-18 | Warnings | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.